IJE Advance Access originally published online on March 28, 2008
International Journal of Epidemiology 2008 37(3):638-640; doi:10.1093/ije/dyn058
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2008; all rights reserved.
Commentary: Hormone therapy and breast cancer incidence: did epidemiologists miss an effect on national trends?
Department of Preventive and Social Medicine, University of Otago Medical School, PO Box 913, Dunedin, New Zealand.
E-mail: charlotte.paul@stonebow.otago.ac.nz
Accepted 27 February 2008
| The first 10% of the full text of this article appears below. |
Publication of the Women's Health Initiative trial of post-menopausal hormone therapy caused re-thinking and heart-searching in epidemiology,1 although the scale of the upset at that time can be exaggerated. As Krieger and colleagues have pointed out elsewhere, biological, clinical and epidemiological evidence questioning the purported benefits of hormone therapy on heart disease and counting the harms had been available well before 2002.2
Krieger in this volume has turned to the effects of hormone therapy on breast cancer risk and asks an important question: if the effect of hormone therapy on breast cancer was established from the 1970s, why was so little attention paid to the effects of hormone therapy on national breast cancer rates?3 Breast cancer
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. D. Smith 'Something funny seems to happen': J.B.S. Haldane and our chaotic, complex but understandable world Int. J. Epidemiol., June 1, 2008; 37(3): 423 - 426. [Full Text] [PDF] |
||||
